Copyright Reports & Markets. All rights reserved.

Global Gefitinib API Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    Global Gefitinib API Market Insights, Forecast to 2025

      1 Study Coverage

      • 1.1 Gefitinib API Product Introduction
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Gefitinib API Market Size Growth Rate by Type
        • 1.4.2 Purity ≥ 98 %
        • 1.4.3 Purity ≥ 99 %
      • 1.5 Market by Application
        • 1.5.1 Global Gefitinib API Market Size Growth Rate by Application
        • 1.5.2 Gefitinib Tablets
        • 1.5.3 Other
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Gefitinib API Production
        • 2.1.1 Global Gefitinib API Revenue 2014-2025
        • 2.1.2 Global Gefitinib API Production 2014-2025
        • 2.1.3 Global Gefitinib API Capacity 2014-2025
        • 2.1.4 Global Gefitinib API Marketing Pricing and Trends
      • 2.2 Gefitinib API Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Gefitinib API Manufacturers
          • 2.3.2.1 Gefitinib API Manufacturing Base Distribution, Headquarters
          • 2.3.2.2 Manufacturers Gefitinib API Product Offered
          • 2.3.2.3 Date of Manufacturers Enter into Gefitinib API Market
      • 2.4 Market Drivers, Trends and Issues

      3 Market Size by Manufacturers

      • 3.1 Gefitinib API Production by Manufacturers
        • 3.1.1 Gefitinib API Production by Manufacturers
        • 3.1.2 Gefitinib API Production Market Share by Manufacturers
        • 3.1.3 Global Market Concentration Ratio (CR5 and HHI)
      • 3.2 Gefitinib API Revenue by Manufacturers
        • 3.2.1 Gefitinib API Revenue by Manufacturers (2014-2019)
        • 3.2.2 Gefitinib API Revenue Share by Manufacturers (2014-2019)
        • 3.2.3 Global Gefitinib API Market Concentration Ratio (CR10 and HHI)
      • 3.3 Gefitinib API Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Gefitinib API Production by Regions

      • 4.1 Global Gefitinib API Production by Regions
        • 4.1.1 Global Gefitinib API Production Market Share by Regions
        • 4.1.2 Global Gefitinib API Revenue Market Share by Regions
      • 4.2 North America
        • 4.2.1 North America Gefitinib API Production
        • 4.2.2 North America Gefitinib API Revenue
        • 4.2.3 Key Players in North America
        • 4.2.4 North America Gefitinib API Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Gefitinib API Production
        • 4.3.2 Europe Gefitinib API Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Gefitinib API Import & Export
      • 4.4 China
        • 4.4.1 China Gefitinib API Production
        • 4.4.2 China Gefitinib API Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Gefitinib API Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Gefitinib API Production
        • 4.5.2 Japan Gefitinib API Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Gefitinib API Import & Export

      5 Gefitinib API Consumption by Regions

      • 5.1 Global Gefitinib API Consumption by Regions
        • 5.1.1 Global Gefitinib API Consumption by Regions
        • 5.1.2 Global Gefitinib API Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Gefitinib API Consumption by Application
        • 5.2.2 North America Gefitinib API Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Gefitinib API Consumption by Application
        • 5.3.2 Europe Gefitinib API Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Gefitinib API Consumption by Application
        • 5.4.2 Asia Pacific Gefitinib API Consumption by Regions
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Gefitinib API Consumption by Application
        • 5.5.2 Central & South America Gefitinib API Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Gefitinib API Consumption by Application
        • 5.6.2 Middle East and Africa Gefitinib API Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Gefitinib API Breakdown Dada by Type
      • 6.2 Global Gefitinib API Revenue by Type
      • 6.3 Gefitinib API Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Gefitinib API Breakdown Dada by Application
        • 7.2.1 Global Gefitinib API Consumption by Application
        • 7.2.2 Global Gefitinib API Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Scion Pharm Taiwan
        • 8.1.1 Scion Pharm Taiwan Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Gefitinib API
        • 8.1.4 Gefitinib API Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Farmhispania Group
        • 8.2.1 Farmhispania Group Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Gefitinib API
        • 8.2.4 Gefitinib API Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Chem Genix
        • 8.3.1 Chem Genix Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Gefitinib API
        • 8.3.4 Gefitinib API Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Jeil Pharmaceutical
        • 8.4.1 Jeil Pharmaceutical Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Gefitinib API
        • 8.4.4 Gefitinib API Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Zhuhai Rundu Pharma
        • 8.5.1 Zhuhai Rundu Pharma Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Gefitinib API
        • 8.5.4 Gefitinib API Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Cipla
        • 8.6.1 Cipla Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Gefitinib API
        • 8.6.4 Gefitinib API Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Brawn Laboratories
        • 8.7.1 Brawn Laboratories Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Gefitinib API
        • 8.7.4 Gefitinib API Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 Nischem International
        • 8.8.1 Nischem International Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Gefitinib API
        • 8.8.4 Gefitinib API Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 Zhejiang Hisun Pharmaceutical
        • 8.9.1 Zhejiang Hisun Pharmaceutical Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Gefitinib API
        • 8.9.4 Gefitinib API Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 Qilu Pharmaceutial
        • 8.10.1 Qilu Pharmaceutial Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Gefitinib API
        • 8.10.4 Gefitinib API Product Description
        • 8.10.5 SWOT Analysis

      9 Production Forecasts

      • 9.1 Gefitinib API Production and Revenue Forecast
        • 9.1.1 Global Gefitinib API Production Forecast 2019-2025
        • 9.1.2 Global Gefitinib API Revenue Forecast 2019-2025
      • 9.2 Gefitinib API Production and Revenue Forecast by Regions
        • 9.2.1 Global Gefitinib API Revenue Forecast by Regions
        • 9.2.2 Global Gefitinib API Production Forecast by Regions
      • 9.3 Gefitinib API Key Producers Forecast
        • 9.3.1 North America
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Gefitinib API Production Forecast by Type
        • 9.4.2 Global Gefitinib API Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Gefitinib API Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Gefitinib API Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Gefitinib API Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Gefitinib API Consumption Forecast by Regions 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 South Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Gefitinib API Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Gefitinib API Consumption Forecast by Countries 2019-2025
        • 10.7.2 Turkey
        • 10.7.3 GCC Countries
        • 10.7.4 Egypt
        • 10.7.5 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Gefitinib API Upstream Market
        • 11.1.1 Gefitinib API Key Raw Material
        • 11.1.2 Typical Suppliers of Key Gefitinib API Raw Material
        • 11.1.3 Gefitinib API Raw Material Market Concentration Rate
      • 11.2 Gefitinib API Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Gefitinib API Distributors
      • 11.5 Gefitinib API Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
            • 14.1.1.1 Research Programs/Design
            • 14.1.1.2 Market Size Estimation
            • 14.1.1.3 Market Breakdown and Data Triangulation
          • 14.1.2 Data Source
            • 14.1.2.1 Secondary Sources
            • 14.1.2.2 Primary Sources
        • 14.2 Author Details

        This report researches the worldwide Gefitinib API market size (value, capacity, production and consumption) in key regions like North America, Europe, China and Japan.
        This study categorizes the global Gefitinib API breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

        The following manufacturers are covered in this report:
        Scion Pharm Taiwan
        Farmhispania Group
        Chem Genix
        Jeil Pharmaceutical
        Zhuhai Rundu Pharma
        Cipla
        Brawn Laboratories
        Nischem International
        Zhejiang Hisun Pharmaceutical
        Qilu Pharmaceutial

        Gefitinib API Breakdown Data by Type
        Purity ≥ 98 %
        Purity ≥ 99 %

        Gefitinib API Breakdown Data by Application
        Gefitinib Tablets
        Other

        Gefitinib API Production Breakdown Data by Region
        North America
        Europe
        China
        Japan

        Gefitinib API Consumption Breakdown Data by Region
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
        Central & South America
        Brazil
        Middle East & Africa
        Turkey
        GCC Countries
        Egypt
        South Africa

        The study objectives are:
        To analyze and research the global Gefitinib API capacity, production, value, consumption, status and forecast;
        To focus on the key Gefitinib API manufacturers and study the capacity, production, value, market share and development plans in next few years.
        To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Gefitinib API :
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025
        For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
        Buy now